X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7961) 7961
Newspaper Article (103) 103
Newsletter (88) 88
Magazine Article (54) 54
Book Chapter (31) 31
Transcript (7) 7
Dissertation (2) 2
Book / eBook (1) 1
Book Review (1) 1
Conference Proceeding (1) 1
Journal / eJournal (1) 1
Reference (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6017) 6017
proton pump inhibitors (4464) 4464
male (3491) 3491
female (3106) 3106
middle aged (2427) 2427
gastroenterology & hepatology (2282) 2282
adult (2080) 2080
pharmacology & pharmacy (1898) 1898
omeprazole (1884) 1884
aged (1868) 1868
proton pump inhibitors - therapeutic use (1593) 1593
proton pump inhibitors - administration & dosage (1490) 1490
treatment outcome (1470) 1470
proton pump inhibitor (1243) 1243
lansoprazole (1089) 1089
risk factors (1055) 1055
drug therapy, combination (1026) 1026
helicobacter infections - drug therapy (1022) 1022
proton pump inhibitors - adverse effects (1004) 1004
gastroesophageal reflux - drug therapy (991) 991
helicobacter pylori (973) 973
animals (931) 931
therapy (857) 857
gastroesophageal reflux (856) 856
medicine & public health (800) 800
anti-ulcer agents - administration & dosage (746) 746
omeprazole - administration & dosage (727) 727
care and treatment (726) 726
dosage and administration (721) 721
anti-ulcer agents - therapeutic use (712) 712
aged, 80 and over (701) 701
2-pyridinylmethylsulfinylbenzimidazoles (691) 691
risk (677) 677
drug administration schedule (671) 671
drug interactions (645) 645
drug therapy (640) 640
medicine, general & internal (621) 621
omeprazole - analogs & derivatives (620) 620
research (607) 607
pharmacokinetics (602) 602
time factors (592) 592
rabeprazole (583) 583
double-blind (580) 580
prospective studies (574) 574
pantoprazole (570) 570
health aspects (557) 557
adolescent (554) 554
retrospective studies (543) 543
dose-response relationship, drug (535) 535
management (535) 535
gastroesophageal-reflux disease (534) 534
proton-pump inhibitors (531) 531
internal medicine (530) 530
hydrogen-ion concentration (529) 529
abridged index medicus (524) 524
young adult (523) 523
omeprazole - therapeutic use (521) 521
gastroenterology (496) 496
anti-bacterial agents - administration & dosage (480) 480
esomeprazole (477) 477
infection (467) 467
anti-bacterial agents - therapeutic use (458) 458
helicobacter pylori - drug effects (458) 458
proton pump inhibitors - pharmacology (448) 448
administration, oral (446) 446
disease (439) 439
oncology (427) 427
analysis (424) 424
gastroesophageal reflux disease (408) 408
complications and side effects (403) 403
double-blind method (396) 396
clopidogrel (392) 392
rats (390) 390
amoxicillin - administration & dosage (384) 384
efficacy (379) 379
ulcers (369) 369
drugs (368) 368
endoscopy (368) 368
diagnosis (365) 365
prevention (364) 364
metaanalysis (359) 359
2-pyridinylmethylsulfinylbenzimidazoles - administration & dosage (354) 354
protons (353) 353
omeprazole - pharmacology (349) 349
aspirin (347) 347
histamine h2 antagonists - therapeutic use (340) 340
surgery (338) 338
prevalence (337) 337
clarithromycin - administration & dosage (335) 335
ticlopidine - analogs & derivatives (335) 335
clarithromycin (334) 334
eradication (334) 334
pharmacology/toxicology (330) 330
nonsteroidal antiinflammatory drugs (328) 328
triple therapy (327) 327
patients (324) 324
anti-inflammatory agents, non-steroidal - adverse effects (322) 322
follow-up studies (319) 319
helicobacter-pylori infection (315) 315
amoxicillin (314) 314
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7763) 7763
Japanese (160) 160
German (120) 120
Russian (90) 90
Spanish (68) 68
French (57) 57
Korean (51) 51
Chinese (11) 11
Italian (11) 11
Danish (7) 7
Hungarian (7) 7
Polish (7) 7
Norwegian (6) 6
Czech (5) 5
Dutch (5) 5
Swedish (5) 5
Ukrainian (4) 4
Portuguese (3) 3
Lithuanian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2016, Volume 14, Issue 6, pp. 809 - 815.e1
Journal Article
Gastroenterology, ISSN 0016-5085, 2017, Volume 152, Issue 1, pp. 134 - 141
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 12/2010, Volume 122, Issue 24, pp. 2619 - 2633
proton pump inhibitors | antiplatelet drugs | gastrointestinal hemorrhage | platelet aggregation inhibitors | aspirin | thienopyridine | AHA Scientific Statements | CYTOCHROME-P450 | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | ACID SUPPRESSION | PERCUTANEOUS CORONARY INTERVENTION | CLOPIDOGREL | LOW-DOSE ASPIRIN | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | DISEASE | PERIPHERAL VASCULAR DISEASE | PRASUGREL | PEPTIC-ULCERS | Piperazines - administration & dosage | Prasugrel Hydrochloride | Purinergic P2Y Receptor Antagonists - administration & dosage | Thiophenes - adverse effects | Cardiovascular Diseases - drug therapy | Humans | Thienopyridines - adverse effects | Thienopyridines - metabolism | Piperazines - metabolism | Thiophenes - metabolism | Thiophenes - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - metabolism | Histamine H2 Antagonists - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Drug Interactions | Proton Pump Inhibitors - administration & dosage | Aspirin - adverse effects | Aspirin - metabolism | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - metabolism | Ticlopidine - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - metabolism | Platelet Aggregation Inhibitors - metabolism | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Proton Pump Inhibitors - adverse effects | Thienopyridines - administration & dosage | Risk Factors | Histamine H2 Antagonists - adverse effects | Piperazines - adverse effects | Ticlopidine - analogs & derivatives | Aryl Hydrocarbon Hydroxylases - metabolism | Gastrointestinal Hemorrhage - chemically induced | Gastrointestinal Hemorrhage - prevention & control | Histamine H2 Antagonists - metabolism | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Cytochrome P-450 CYP2C19 | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Proton Pump Inhibitors - metabolism
Journal Article
Gut, ISSN 0017-5749, 01/2018, Volume 67, Issue 1, pp. 28 - 35
Journal Article
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2019, Volume 157, Issue 3, pp. 682 - 691.e2
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 12/2010, Volume 105, Issue 12, pp. 2533 - 2549
... of proton pump inhibitors and thienopyridines: a focused update of the ACCF ACG AHA 2008 expert consensus document on reducing the gastrointestinal risks... 
proton pump inhibitors | aspirin | ACCF Expert Consensus Document antiplatelet drugs | gastrointestinal hemorrhage | thienopyridine | platelet aggregation inhibitors | CYTOCHROME-P450 | MYOCARDIAL-INFARCTION | ACID SUPPRESSION | PERCUTANEOUS CORONARY INTERVENTION | CLOPIDOGREL | LOW-DOSE ASPIRIN | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | DISEASE | PRASUGREL | GASTROENTEROLOGY & HEPATOLOGY | PEPTIC-ULCERS | Piperazines - administration & dosage | Prasugrel Hydrochloride | Purinergic P2Y Receptor Antagonists - administration & dosage | Thiophenes - adverse effects | Cardiovascular Diseases - drug therapy | Humans | Thienopyridines - adverse effects | Thienopyridines - metabolism | Piperazines - metabolism | Thiophenes - metabolism | Thiophenes - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - metabolism | Histamine H2 Antagonists - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Drug Interactions | Proton Pump Inhibitors - administration & dosage | Aspirin - adverse effects | Aspirin - metabolism | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - metabolism | Ticlopidine - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - metabolism | Platelet Aggregation Inhibitors - metabolism | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Proton Pump Inhibitors - adverse effects | Thienopyridines - administration & dosage | Risk Factors | Histamine H2 Antagonists - adverse effects | Piperazines - adverse effects | Ticlopidine - analogs & derivatives | Aryl Hydrocarbon Hydroxylases - metabolism | Gastrointestinal Hemorrhage - chemically induced | Gastrointestinal Hemorrhage - prevention & control | Histamine H2 Antagonists - metabolism | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Cytochrome P-450 CYP2C19 | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Proton Pump Inhibitors - metabolism
Journal Article